RO 5545965
Alternative Names: RO-554965; RO5545965Latest Information Update: 04 Nov 2017
At a glance
- Originator Roche
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Schizophrenia
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for phase-I development in Schizophrenia in USA (PO, Capsule)
- 04 Nov 2017 No recent reports of development identified for phase-I development in Schizophrenia(In volunteers) in United Kingdom (PO, Capsule)
- 24 Apr 2017 Roche completes a phase I trial for Schizophrenia in USA (PO, Capsule) (NCT02824055)